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Molecular characterisation of measles virus is a pow-
erful tool for tracing transmission. Genotyping may 
prove the absence of endemic circulation of measles 
virus, i.e. transmission for more than 12 months, 
which is one of the criteria for verifying elimination of 
the disease. We have genetically characterised mea-
sles viruses detected in Romania from 2008 to 2012, 
focusing on the recent outbreaks from 2010 to 2012 
that affected mainly groups with limited access to 
healthcare and schools. The findings emphasise the 
importance of genotyping during the different phases 
of an outbreak. A total of 8,170 cases were notified, 
and 5,093 (62%) of the 7,559 possible cases were 
serologically confirmed. RT-PCR was performed for 
104 samples: from the 101 positive samples obtained 
from sporadic measles cases or clusters from different 
counties, 73 were genotyped. Sporadic measles cases 
associated with D4 and D5 viruses were observed from 
2008 to 2009. Genotype D4-Manchester was predomi-
nant in 2011 and 2012. In addition, the related variant 
D4-Maramures and MVs/Limoges.FRA/17.10[D4] and a 
few D4-Hamburg strains were detected. The detection 
of several distinct MV-D4 genotypes suggests multiple 
virus importations to Romania. The outbreak associ-
ated with D4 genotype is the second largest outbreak 
in Romania in less than 10 years.
Introduction
Measles is a highly contagious respiratory viral dis-
ease characterised by the appearance of fever and 
a rash and that can be very serious or even fatal. 
Measles remains one of the leading causes of mortal-
ity in young children although a safe and cost-effective 
vaccine has been available for decades [1]. Although 
improvements have been made to control measles in 
Europe, large-scale outbreaks have recently still been 
observed [2-7]. The World Health Organization (WHO) 
was forced to postpone a number of times the target 
date for measles elimination from the European region, 
most recently to 2015 [8].
Measles has been a statutorily notifiable disease in 
Romania since 1978, and medical practitioners must 
report all clinically possible measles cases to the 
regional public health authorities. The first monova-
lent measles-containing vaccine was introduced in 
1979 into the Romanian vaccination schedule for chil-
dren aged nine to 11 months. The combined measles-
mumps-rubella (MMR) vaccine replaced the monovalent 
measles vaccine in 2004 and was recommended as a 
first dose for children aged 12 to 15 months. The sec-
ond MMR vaccine dose has been recommended since 
October 2005 for children aged six to seven years. In 
the period from 2000 to 2010, the coverage for the first 
dose of measles vaccine was estimated at 95–98% [9]. 
In 2011, measles vaccination coverage for the first dose 
of MMR vaccine was estimated at 84% for children aged 
12 months and 93.2% for those aged 18 months [10].
Romania experienced a measles epidemic that started 
in December 2004 and lasted until early 2007 [11]. More 
than 9,000 cases were detected mostly in non-immu-
nised patients belonging to the Roma ethnic group. 
The outbreak was caused by the strain MVs/Bucharest.
ROM/48.04/2[D4] and variants divergent by two nucle-
otides or less were detected during the period 2004 to 
2006 [11]. Closely related strains were detected from 
2005 to 2007 in Bosnia and Herzegovina, Germany, 
Italy, Portugal, Serbia, Spain and Switzerland [11-
12]: outbreaks associated with MVs/Bucharest.
ROM/48.04/2[D4] occurred in 2005 in Germany (223 
cases in Hesse, MVs/Frankfurt.DEU/03.05[D4]) [13] and 
from August 2006 to February 2007 in Spain (over 200 
cases in Catalonia, MVs/Barcelona.SPA/41.06/1[D4]) 
[11].
D4 measles viruses are endemic in India, South-East 
Asia and in South Africa [14]. Outbreaks associated 
with this genotype have been reported since 2007 
from all continents. In Europe, many distinct variants 
descend from D4-Enfield (MVs/Enfield.GBR/14/07) 
which became endemic in the United Kingdom (UK) in 
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2007 [15-17]. The variant D4-Hamburg initiated a trans-
mission chain of 25,000 cases that was detected in 
Europe for a period of more than two years, 2009 to 
2011 [18]. In 2010, the D4 genotype became predomi-
nant in Europe [2].
Genetic characterisation of measles viruses constitutes 
an important part of laboratory surveillance. Molecular 
epidemiology confirms the transmission pathway of 
measles virus, thereby complementing classical epi-
demiology. Moreover, interruption of endemic measles 
virus transmission (i.e. circulation of a certain variant 
for more than 12 months) is an important criterion for 
verification of measles virus elimination in Europe. 
Therefore, it is necessary to distinguish between 
endemic and imported viruses using molecular meth-
ods [16].
This study describes the genetic characterisation of 
measles viruses detected in Romania from 2008 to 
2012, focusing on the recent outbreaks that occurred 
in the country between 2010 and 2012 that affected 
mainly groups with limited access to healthcare facili-
ties and schools. This study underlines the importance 
of measles genotyping during the different phases of 
an outbreak.
Methods
Patients and specimens collection
According to the national strategy of measles surveil-
lance, approved by Romanian MOH, a measles case 
is defined as a person with fever and maculopapu-
lar rash and at least one of the following symptoms: 
cough, coryza, or conjunctivitis. Possible cases are 
persons who met the clinical case definition with no 
epidemiological link to a laboratory-confirmed case. 
Confirmed cases are either laboratory-confirmed (by 
detecting measles IgM antibodies in serum samples, 
virus isolation, a significant rise in measles antibody 
levels, or measles PCR detection in all possible cases) 
or confirmed by the presence of measles case symp-
tomatology and an epidemiological link to a labora-
tory-confirmed case. 
At national level, notifications of measles cases are 
collected and analysed by the National Centre for 
Communicable Diseases Surveillance and Control in 
Bucharest, Romania. Specimens are sent for confirma-
tion to the National Reference Laboratory for Measles 
and Rubella in Cantacuzino Institute, Bucharest, 
Romania.
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Serum samples were tested for measles-specific IgM 
using Enzygnost Anti-Measles-Virus/IgM according to 
the manufacturer’s instructions (Siemens Healthcare 
Diagnostics Products GmbH). 
RT-PCR and sequencing
Confirmed cases were selected for genotyping from 
new outbreaks (index case and two or three secondary 
cases). All confirmed cases with a history of travel 
abroad during the incubation period (7–21 days) were 
genotyped.
For measles virus genotyping, DNA fragments were 
generated by a nested RT-PCR recommended by 
WHO, which targeted the 450 nt region encoding the 
C-terminus of the nucleoprotein, as described pre-
viously [19], using the QIAGEN OneStep RT PCR Kit 
(QIAGEN, Hilden, Germany). Gel purification was per-
formed with Wizard SV Gel and PCR Clean-Up System 
Table 
Molecular characterisation of wildtype measles viruses and relationship of genotypes and epidemiological activity, Romania, 
2008–12 
Detection period Measles virus strain Measles virus genotype/variant Imported from Epidemiological remarks
March 2008 MVs/Dolj.ROU/13/08/1 D4-Enfield Italy 1 sporadic case in Dolj
April 2008 MVs/Bucharest.ROU/20.08/ MVs/Lucerne.SWI/46.06[D5] Greece 1 sporadic case in Bucharest
August 2009 MVs/Arad.ROU/35.09/1 D4-Hamburg Ireland Small cluster (5 cases) in Arad,
2010:  8 districts affected
February–March MVs/Tulcea.ROU/08.10/ D4-Manchester France Small clusters (5 cases) in Tulcea 
April–May MVs/Timis.ROU/18.10/1 D4-Hamburg Unknown 2 cases in Timis (siblings)
June MVs/Neamt.ROU/26.10/ MVs/Limoges.FRA/17.10/[D4] Unknown Small cluster (3 cases)  in Neamt; 1 case in Timis
August MVs/Neamt.ROU/34.10/ MVs/Limoges.FRA/17.10/[D4] Unknown Nosocomial outbreak (28 cases, 1 death) in Neamt 
September MVs/Vaslui.ROU/39.10/ MVs/Paris.FRA/40.10[G3] France 1 sporadic case in Vaslui,
October 2010–
September 2011 MVs/Maramures.ROU/03.11 D4-Maramures Unknown 615 cases in Maramures
2011: 39 of 41 districts plus Bucharest affected
March MVs/Buzau.ROU/12.11/ D4 Turkey 2 sporadic cases in Buzau
April MVs/Calarasi.ROU/16.11/ B3 Spain 1 sporadic case in Calarasi
October MVs/Tulcea.ROU/41.11/ B3 Unknown 1 sporadic case in Tulcea
November MVs/Buzau.ROU/46.11/ D8 Italy 1 case in Buzau
February–November MVs/Ialomita.ROU/06.11/MVs/Bucuresti.ROU/44.1/1 D4-Manchester Not imported
Galati (25 cases), Sibiu (17),  
Caras-Severin (132),  Arges (2), 
Constanta (190), Giurgiu (20), 
Bucuresti (49), Ialomita (30)
2012: All districts affected
January–June MVs/Ilfov.ROU/01.12/ MVs/Ilfov.ROU/23.12/ D4-Manchester Indigenous
Ilfov (50 cases), Iasi (383), and 
Ialomita (92)
April MVs/Brasov.ROU/14.12/ D4-Maramures Indigenous 62 cases in Brasov
June–July MVs/Gorj.ROU/26.12/ MVs/Olt.ROU/28.12/ D8 - Frankfurt Main Unknown
2 sporadic cases in Gorj and 
neighbouring Olt district
August MVs/Brasov.ROU/35.12/ D4- Maramures Indigenous 16 cases in Brasov
September
MVs/Arges.ROU/36.12/ 
MVs/Olt.ROU/37.12/ D4-Manchester Indigenous 
1 sporadic case in Olt and 
outbreak in Arges (72), 
MVs/Prahova.ROU/37.12/ D8 - Frankfurt Main Unknown 1 sporadic case in Prahova,
October
MVs/Suceava.ROU/41.12/ D8 - Frankfurt Main Not imported 5 sporadic cases (1 death) in different parts of the county
MVs/Suceava.ROU/41.12/3 D4- Manchester Indigenous 1 sporadic case in Suceava
MVs/Brasov.ROU/44.12/
MVs/Dolj.ROU/43.12/ D4- Manchester Indigenous
2 sporadic cases in Brasov 
and Dolj
November MVs/Calarasi.ROU/47.12/ D4- Manchester Indigenous 1 sporadic case in Calarasi,
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Promega (Fitchburg, Wisconsin). Sequencing was 
performed with the second round primers  [19] using 
ABI PRISM BigDye Terminator v3.1 Ready Reaction 
Cycle Sequencing kit (Applied Biosystems Foster City, 
California) on a four-capillary ABI PRISM 3100-Avant 
Genetic Analyzer (Applied Biosystems Foster City, 
California).
Sequence analysis
Sequences were edited manually with BioEdit (ver-
sion 7.0.5; North Carolina State University) and with 
the use of Staden Package [20]. Partial nucleocap-
sid gene sequences were aligned against related 
sequences retrieved from GenBank and MeaNS (http://
www.who-measles.org) databases, using ClustalW [21] 
implemented in BioEdit (version 7.1.3.0) [22]. Starting 
with 2011, the programmes BioEdit and Gap4 have been 
replaced by the commercial programme Sequencer 
(Gene Codes Corporation, Ann Arbor, United States).
Phylogenetic analysis was performed using MEGA (ver-
sion 5) with a neighbour-joining (NJ) algorithm inferred 
with Tamura-Nei parameter for sequence evolution.
Results
Romania experienced a measles epidemic with contin-
uous virus transmission from late 2004 to early 2007. 
In the following years 2008 and 2009, measles activity 
Figure 2
Localisation of different measles virus genotypes and D4 variants and confirmed cases detected in Romania in 2008–12 
(n=73)
For the outbreak dots that do not have a genotype assigned, genotyping was not performed. The genotype label is associated with outbreaks 
dots within the county’s geographical boundary.
D4 MM (D4-Maramures) 
D4 M (D4-Manchester)
D4 L (MVs/Limoges.FRA/17.10/)
















































































































































































was very low (12 cases in 2008; eight cases in 2009), 
all notified cases were imported by travellers coming 
from other European countries, leading to an incidence 
of less than 0.1 per 100,000 persons. The number of 
measles cases then increased again considerably in 
2010 to 2012, reaching a total of 8,170 notified cases, 
of which 5,093 (62%) have been laboratory-confirmed 
(Figure 1).
From 2010 to 2012, a total of 104 possible cases were 
subjected to measles virus detection by RT-PCR (101 
positive) and 73 were genotyped. The results of these 
investigations are summarised in the Table.
Measles cases in 2008
In March 2008, a sporadic case was notified in Dolj 
county (MVs/Dolj.ROU/13/08/1[D4]). This case was 
imported from Italy and had an identical sequence 
to MVs/Enfield.GBR/14.07[D4]. No secondary 
cases were detected. Another sporadic case was 
detected in Bucharest in April 2008 (MVs/Bucharest.
ROU/20.08[D5]). This virus was imported from Greece 
and had an identical sequence to MVs/Lucerne.
CHE/46.06[D5], the strain that caused a large outbreak 
of more than 4,400 cases in Switzerland between 2006 
and 2009.
Measles cases in 2009
In August 2009, in Arad county, a small cluster of five 
measles cases was laboratory-confirmed by IgM. The 
index case was a child too young to be vaccinated 
returning from Ireland, who infected two other family 
members. One of them was hospitalised and passed 
the infection nosocomially to two additional cases 
in the paediatric ward. Genotyping a specimen from 
one of the secondary cases identified a measles virus 
(MVs/Arad.ROU/35.09/1[D4]) that was closely related 
to MVs/Limoges.FRA/17.10[D4] with a single nucleotide 
mismatch. As a response measure, the National Center 
for Surveillance and Control of Transmissible Diseases 
(CNSCBT) coordinated a supplementary vaccination 
campaign in the neighbouring Arad and Timis districts, 
targeting 1,054 unvaccinated or single-dose vaccinated 
children.
Measles cases in 2010
In 2010, measles activity increased to nine sporadic 
cases in five counties and 185 outbreak-related cases 
from in eight counties. Characteristic in that year was 
the occurrence of outbreaks in different geographic 
areas of the country, in the east (Neamt and Galati with 
31 cases each) and in the north-west (Maramures with 
95 cases) (Figure 2).
The first cluster occurred in February to March, in a 
Roma community from Tulcea county, totalling five 
cases. The index case had travelled to France shortly 
before. Genotyping of the strain isolated from the 
index case revealed MVs/Tulcea.ROU/08.10[D4], iden-
tical over the sequenced fragment to MVs/Manchester.
GBR/10.09[D4] (Figure 3). Variant D4–Manchester had 
circulated since 2008 in the UK and in France (MVs/
Montaigu.FRA/43.08[D4], MVs/Paris.FRA/18.10[D4]).
In May 2010, two cases were confirmed in Timis county, 
in siblings without a recent travel history. The identi-
cal sequences found in these two cases, MVs/Timis.
ROU/18.10/1[D4], differed by one nucleotide from the 
strain that caused the small cluster in the previous 
year (MVs/Arad.ROU/35.09/1[D4]), and were identical 
to D4-Hamburg (Figure 3). 
Two outbreaks were notified in the summer of 2010 in 
Neamt county. The first outbreak occurred in June in a 
Roma community with three confirmed cases. The sec-
ond outbreak started in August as a nosocomial infec-
tion in the paediatric ward of a hospital, resulting in 
28 cases with one infant fatality. The sequences from 
both outbreaks (MVs/Neamt.ROU/26.10[D4] and MVs/
Neamt.ROU/34.10[D4]) were identical to MVs/Limoges.
FRA/17.10[D4] (Figure 3).
In October 2010, several outbreaks were notified in 
Galati, reaching 31 cases by the end of the year. The 
involved sequences (MVs/Galati.ROU/42.10/1[D4]) were 
identical to MVs/Limoges.FRA/17.10[D4], as well as the 
strains from Neamt. Strain MVs/Timis.ROU/50.10/1[D4], 
genotyped from two epidemiologically linked cases 
detected in December 2010 in Timis county, differed by 
two nucleotides.
An imported case was detected in a student who 
travelled from Paris to Vaslui in September 2010. 
Sequencing revealed MVs/Vaslui.ROU.40.10[G3], iden-
tical to the strain MVs/Paris.FRA/47.10[G3] MV which 
circulated in France in 2010, but was also detected in 
Germany, the UK and Spain (Figure 4).
Measles cases in 2011
In 2011, outbreaks expanded to 39 of the 42 counties 
of Romania, reaching 4,163 notified cases (45.9% labo-
ratory-confirmed). Because the epidemic was so large, 
measles virus genotyping and phylogenetic analy-
sis was restricted only to extended outbreaks and to 
imported cases. The majority of genotyped cases were 
associated with D4-Manchester and D4-Maramures 
variants (Figures 2 and 3). The cases were mainly seen 
in the north-western region of Romania, first in the 
Roma communities and subsequently spreading into 
the general population. The Salaj county was most 
affected (incidence: 141.9 per 100,000 population). 
Of the total laboratory-confirmed cases in 2011, 78% 
were not vaccinated. Of these, 16% were younger than 
12 months and thus not eligible for vaccination. As a 
response measure to the growing number of measles 
cases, additional vaccination campaigns were imple-
mented in 2011 that targeted children between the 
ages of seven months and seven years, leading to 
approximately 4,500 vaccinated children. 
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Romanian MV strains are highlighted in different colours.  
GenBank accession numbers: MVi/Galati.ROU/20.11, JX156445; 
MVs/Bucuresti.ROU/19.11/1, JN615582; MVs/Timis.ROU/18.10/1, 
HQ704313; MVs/Arad.ROU/35.09/1, HQ704310; MVs/Tulcea.
ROU/08.10, HQ704312; MVs/Timis.ROU/12.11, JN599040; MVs/
Timis.ROU/11.11, JX841118; MVs/Arad.ROU/10.11/1, JN599037; MVs/
Neamt.ROU/10.11, JN599039; MVs/Bihor.ROU/08.11, JN599033; 
MVs/Ilfov.ROU/08.11, JN599034; MVs/Ialomita.ROU/08.11/2, 
JN599036; MVs/Ilfov.ROU/07.11, JX841117; MVs/Ilfov.ROU/06.11, 
JX841116; MVs/Bihor.ROU/06.11, JX841115; MVs/Maramures.
ROU/03.11, JX841109; MVs/Neamt.ROU/08.11, JX841114; MVs/
Arad.ROU/08.11, JX841113; MVs/Brasov.ROU/14.12/1, JX156442; 
MVs/Brasov.ROU/14.12/2, JX156443; MVs/Ialomita.ROU/08.11, 
JN599035; MVs/Constanta.ROU/19.11/3, JN615580; MVs/Caras-
Severin.ROU/36.11/1, JN873033; MVs/Giurgiu.ROU/26.11/1, 
JN615577; MVs/Sibiu.ROU/12.11/, JN599041; MVs/Ialomita.
ROU/06.11, JX841112; MVs/Neamt.ROU/26.10/1, HQ704314; 
MVs/Neamt.ROU/34.10/1, HQ704315; MVs/Galati.ROU/42.10/1, 
HQ902906; MVs/Bucuresti.ROU/26.11/3, JX841111; MVs/Timis.
ROU/50.10/1, HQ902905; MVs/Arges.ROU/19.11/2, JN615581; MVs/
Timis.ROU/25.11, JN615579; MVs/Bucuresti.ROU/44.11, JQ417670; 
MVs/Bucharest.ROU/48.04/2, AM849093; MVs/Galati.ROU/47.11, 
JQ417669; MVs/Iasi.ROU/12.12, JX157884; MVs/Ialomita.
ROU/13.12, JX156444; MVs/Ilfov.ROU/01.12, JQ809707; MVs/Buzau.
ROU/13.11, JN599042; MVs/Buzau.ROU/12.11, JX841110; Montreal.
CAN/89, U01976; MVs/London.GBR/29.11/3, NA; MVs/Ljubljana.
SVN/26.11, NA; MVs/Paris.FRA/11.11/4, NA; MVs/Lyon.FRA/03.11/, 
NA; MVs/Edinburgh.GBR/20.11/3, NA; MVs/Birmingham.GBR/7.12, 
NA; MVs/Heidelberg.DEU/06.11, NA; MVs/Hamburg.DEU/03.09, 
HQ436108; MVs/Belgrad.SRB/26.10, NA; MVs/Muenchen.
DEU/22.10, HQ704350; MVs/Pyrgos.GRC/08.10/4, HM366144; 
MVs/Vienna.AUT/13.10, HQ704298; MVs/Dublin.IRL/1.10, NA; 
MVs/Paris.FRA/16.11/3, NA; MVs/Marseille.FRA/01.11/2, NA; MVs/
Embrun.FRA/07.11, NA; MVs/Gloucester.GBR/13.10, HM215515; 
MVs/Marseille.FRA/16.11, NA; MVi/Falaise.FRA/16.10, FR671445; 
MVi/Villejuif.FRA/20.10, FR671446; MVs/Belfast.GBR/50.09, 
GU479875; MVs/Enfield.GBR/14.07, EF600554; MVs/Gloucester.
GBR/12.10, HM215515; MVs/Istanbul.TUR/20.10, HM579947; MVs/
Limoges.FRA/17.10, FR671430; MVs/London.GBR/5.09, GU120179; 
MVs/Montaigu.FRA/43.08, GQ428173; MVs/Nantes.FRA/44.08, 
GQ428179; MVs/Paris.FRA/18.10, FR671444; MVs/Poitiers.
FRA/47.08, GQ428172; MVs/Pyrgos.GRC/13.10/3, HM802123; MVs/
Thess.GRE/4.10, HM770085; MVs/Toulouse.FRA/07.10, FR671432; 
MVs/Dolj.ROU/13.08/1, HQ704311; MVs/Arad.ROU/38.07/2, 
HQ704309; MVs/Shumen.BGR/15.09/1, HQ436103; MVs/Plovdiv.
BGR/23.10/1, HQ436106; MVs/Pyrgos.GRC/13.10, HM802123; 
MVs/Manchester.GBR/10.09, GQ370461; MVs/Montpellier.
FRA/17.10, FR671431; MVs/SaintMande.FRA/17.10, FR671435; 
MVi/Bandarlengeh.IRA/07.10/1, HM440228; MVi/Bandarabas.
IRA/05.10/2, HM440227; MVs/Isfahan.IRA/22.10, HQ395674; MVs/
Ilfov.ROU/23.12, JX847792; MVs/Brasov.ROU/35.12, NA; MVs/
Arges.ROU/36.12/2, JX912278; MVs/Arges.ROU/36.12, JX912279; 
MVs/Olt.ROU/37.12, NA; MVs/Calarasi.ROU/40.12, NA; MVs/
Suceava.ROU/43.12/3, KC172854; MVs/Dolj.ROU/43.12/2, NA; MVs/
Dolj.ROU/43.12, NA; MVs/Suceava.ROU/43.12/3, NA; MVs/Brasov.
ROU/44.12, NA; MVs/Calarasi.ROU/47.12, NA.
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Figure 4
Phylogenetic tree of sporadic cases infected with measles virus genotypes G3, B3, D8 and D5 detected in Romania, 2008–12 
(n=13), in relation to reference strains 
Romanian MV strains are highlighted in different colours
GenBank accession numbers: MVs/Tulcea.ROU/41.11, JX847793; MVs/Calarasi.ROU/16.11, JN615583; MVs/Buzau.ROU/46.11, JQ417668; 
New York.USA/94, L46753; Ibadan.NIE/97/1, AJ232203; Manchester.UNK/30.94, AF280803; MVs/Gorj.ROU/26.12, JX497760; MVs/Vaslui.
ROU/39.10, JX497759; Palau.BLA/93, L46758; Bangkok.THA/93/1, AF079555; MVs/Imphal.IND/29.11/2, JQ687144; MVs/SaintMande.FRA/42.10, 
FR848083; MVs/Paris.FRA/47.10, FR848086; MVs/SaintMande.FRA/44.10, FR848084; MVs/Madrid.ESP/39.10, HQ712117; MVs/Bucharest.
ROU/20.08, NA; MVs/Ljubljana.SVN/24.11, NA; MVs/London.GBR/27.11/6, NA; MVs/Lucerne.CHE/46.06, NA; Gresik.INO/17.02, AY184217; 
MVs/Barcelona.ESP/48.10, JF681232; MVs/Barcelona.ESP/3.11, JF681246; MVs/Dresden.DEU/49.10, NA; MVs/Istanbul.TUR/27.12/3,NA; MVs/
Frankfurt-Main.DEU/17.11, NA; MVs/Nuernberg.DEU/24.11, NA; MVs/Muenchen.DEU/20.11, NA; 
MVs/Guildford.GBR/7.12, NA; MVi/Villupuram.IND/03.07, FJ765078; MVs/Georgia.USA/25.12, JX402879; MVs/Olt.ROU/28.12, JX497758; 
MVs/Beitbridge.ZWE/46.10, NA; MVs/Prahova.ROU/37.12, NA; MVs/Suceava.ROU/41.12, JX982115; MVs/Suceava.ROU/43.12/2, KC172853; 













































Several outbreaks leading to 520 cases started 
in Maramures county in October 2010 and contin-
ued until September 2011. Genotyped cases from 
these outbreaks revealed a new D4 variant MVs/
Maramures.ROU/03.11[D4], which differed by one 
nucleotide from D4-Manchester. D4–Maramures was 
also detected in 2011 in several other counties: Arad, 
Neamt, Bihor (MVs/Arad.ROU/10.11/1[D4], MVs/Arad.
ROU/10.11/1/2[D4], MVs/Neamt.ROU/10.11[D4], and 
MVs/Bihor.ROU/06.11[D4]) as well as in 2012 in Brasov 
county (MVs/Brasov.ROU/14.12/1[D4] and MVs/Brasov.
ROU/44.12/1[D4]). The new variant D4-Maramures 
was exported in 2011 to Slovenia (MVs/Ljubljana.
SVN/26.11[D4]), France (MVs/Paris.FRA/11.11/4[D4]), 
the UK (MVs/London.GBR/29.11/3[D4]) and the United 
States (US) (MVs/Florida.USA/28.11/1) (Figure 3). 
Several strains diverging by a single nucleotide from 
variant D4–Maramures were detected in Ilfov county: 
MVs/Ilfov.ROU/06.11[D4], MVs/Ilfov.ROU/07.11[D4] and 
MVs/Ilfov.ROU/08.11[D4] as well as in Ialomita county 
(MVs/Ialomita.ROU/08.11/2[D4]). The transmission of 
this divergent strain was interrupted in February 2011.
Besides the epidemic caused by D4-Manchester and 
D4-Maramures, we identified new imported cases: a 
single sporadic case with measles genotype B3 was 
detected in April 2011 in Calarasi county. This case 
(MVs/Calarasi.ROU/16.11[B3]) was a teenager who 
had travelled to Spain. Phylogenetic analysis of this 
case revealed 100% identity with MVs/Barcelona.
ESP/48.10[B3] detected in 2010 to 2011 in Spain 
(Granada, Balearic Islands and Barcelona) (Figure 4). 
This import apparently did not spread further. However, 
another case with an identical sequence (MVs/Tulcea.
ROU/41.11[B3]) was detected 25 weeks later in the 
neighbouring Tulcea county. 
Two sporadic D4 cases were identified in March 
2011 in Buzau county. The index case (MVs/Buzau.
ROU/12.11[D4]) had travelled to Turkey, and an isolate 
from a secondary case (MVs/Buzau.ROU/13.11[D4]) 
revealed a single nucleotide exchange compared to 
strains circulating in 2010 in Iran (MVi/Bandarlengeh.
IRA/07.10/1[D4] (Figure 4). 
Measles virus MV-D8 (MVs/Buzau.ROU/46.11[D8]) was 
also detected in November 2011 in Buzau county in a 
person with no recent travel history. The index case of 
this measles virus importation was not identified, and 
no secondary cases were detected. Phylogenetic analy-
sis of this case revealed close relation with the variant 
D8-Frankfurt Main (Figure 4).
Measles cases in 2012
In 2012, measles activity remained at comparable inten-
sity to the previous year, reaching 4,006 cases (79.3% 
laboratory-confirmed) by the end of year, but the geo-
graphical distribution shifted to the south-eastern 
region of Romania. Of all laboratory-confirmed cases 
in 2012, 84.5% were unvaccinated (26.7% too young 
for vaccination). The most affected age group were chil-
dren younger than one year (incidence: 219/100.000) 
and those between one and four years of age (inci-
dence: 78.6/100.000). The majority of these cases 
were associated with D4-Manchester variant (Figures 2 
and 3). According to the national strategy of measles 
cluster control, vaccination of children aged between 
seven month and seven years continued in 2012, but 
the total number of vaccinations is not available.
Two sporadic measles cases infected with MV-D8 with 
identical sequences were detected in June in Gorj 
county (MVs/Gorj.ROU/26.12[D8]) and in July in the 
neighbouring Olt county, (MVs/Olt.ROU/28.12[D8]). 
These two strains belonged to the variant D8-Frankfurt-
Main (MVs/Frankfurt Main.DEU/17.11[D8]) that was 
detected in Germany between February and June 
(MVs/Muenchen.DEU/20.11[D8] and MVs/Nuernberg.
DEU/24.11[D8]), the UK (MVs/Guildford.GBR/7.12[D8]), 
the US (MVs/Georgia.USA/25.12/ [D8]) and Turkey 
(MVs/Istanbul.TUR/27.12/3[D8]), in 2011 to 2012 (Figure 
4).
A fatal measles case in a young teenager (vaccinated 
with two doses of MMR), registered in secondary 
school without any underlying health problems, was 
recorded in October 2012 in Suceava county. MVs/
Suceava.ROU/41.12[D8] also belonged to D8-Frankfurt-
Main and was identical to MVs/Gorj.ROU/26.12[D8], 
MVs/Olt.ROU/28.12[D8], MVs/Prahova.ROU/37.12[D8] 
and MVs/Suceava.ROU/44.12[D8] (Figure 4). Two cases 
with a single nucleotide difference were identified 
(MVs/Suceava.ROU/43.12/[D8]) (Figure 4). In summary, 
8 MV-D8 cases were identified in 2012, five of them in 
Suceava. 
Discussion
The 20 measles cases notified during 2008 to 
2009 were attributed to MV-D4 and MV-D5 viruses 
imported from neighbouring countries and were not 
passed on to the general population. The situation 
changed with three outbreaks in 2010 in Tulcea and 
Neamt (MVs/Tulcea.ROU/08.10[D4]), (MVs/Neamt.
ROU/26.10[D4]). The outbreak in Tulcea was caused 
by a D4-Manchester variant, whereas the viruses from 
Neamt and Galati (MVs/Neamt.ROU/26.10/1[D4], MVs/
Galati.ROU/42.10/1[D4]) exhibited an amino acid sub-
stitution to D4-Manchester (I469L) that had previously 
been found only in a few French sequences depos-
ited in GenBank (MVs/Toulouse.FRA/07.10[D4], MVs/
Limoges.FRA/17.10[D4]) and in one strain from the UK 
(MVs/Gloucester.GBR/12.10[D4]). This finding makes 
prior undetected circulation of Measles Virus related 
to MVs/Neamt.ROU/26.10/1[D4] in early 2010 unlikely. 
It can be therefore assumed, that the Tulcea cluster 
in early 2010 and the outbreak in Neamt in mid-2010 
were linked to separate importations (Figure 3). The 
two cases from Timis detected in December 2010 (MVs/
Timis.ROU/50.10/1[D4]) had two nucleotide differences 
compared with sequences from the outbreak in Neamt 
and Galati, indicating a different source as well. The 
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strain MVs/Timis.ROU/50.10/1[D4] did have the substi-
tution I469L like the sequences from the outbreak in 
Neamt, but shared two additional nucleotide changes 
with the strains circulating in France and the UK. The 
cases from the Timis and Neamt outbreaks may have 
been introduced from different sources but their 
genetic sequences indicate a similar origin.
The variant D4-Manchester was imported in early 2010 
and caused a small outbreak in Tulcea (MVs/Tulcea.
ROU/08.10[D4]), but was apparently re-imported in early 
2011 to Ialomita (MVs/Ialomita.ROU/06.11[D4]) and was 
detected as late as November 2012. Genotyped viruses 
in 2011 to 2012 from outbreaks in a wide geographi-
cal distribution (Ialomita, Sibiu, Arges, Constanta, 
Timis, Giurgiu, Caras-Severin  Bucuresti, Galati, Ilfov, 
and Iasi, the latter with a single nucleotide mismatch) 
were identical to MVs/Tulcea.ROU/08.10[D4] (Figures 2 
and 3). There is no indication of continuous circulation 
of D4-Manchester during the period between February 
2010 and February 2011; our results suggest that it was 
imported for the second time in early 2011. However, 
it is possible that some measles cases went unnoticed 
clinically, some time after February 2010 and before 
February 2011, making the time window in which 
D4-Manchester did not circulate shorter than indicated 
by our data. Variant D4-Manchester apparently co-
circulated with D4-Maramures in 2011 (D4-Manchester 
mainly in the south-east and D4-Maramures in western 
and central Romania) but became predominant in 2012.
Variant D4-Maramures was widely detected in 2011 and 
last in October 2012 in Brasov county. Because of their 
phylogenetic relationship and local and temporal dis-
tribution, it can be assumed that D4-Maramures and 
MVs/Ilfov.ROU/06.11[D4] represent first- and second-
generation descendants of D4-Manchester. Thus, the 
total number of measles cases attributed to the main 
transmission chain had reached at least 7,300 noti-
fied cases by the end of 2012. We could demonstrate 
the establishment of D4-Manchester and its descend-
ants as new endemic strains in Romania, circulating 
continuously for a time period of almost two years 
(February 2011 to November 2012). The outbreak from 
2011 to 2012 associated with D4-Manchester is the sec-
ond large outbreak of D4 genotype in Romania within a 
period of less than 10 years.
In response to the measles outbreaks, a wide range 
of control measures were implemented, including 
strengthened surveillance for timely identification and 
monitoring of cases and outbreaks, modified immu-
nisation schedules, and supplementary immunisa-
tion activities (approximately 4,500 vaccinated) of the 
rural population. Despite these measures, more than 
4,000 of the over 30,000 cases recorded in Europe in 
2011 were from Romania [23]. In 2012, 3,843 of 8,230 
total cases were reported by Romania to The European 
Surveillance System [24].
Frequent measles outbreaks in Romania could be 
the result of suboptimal vaccine coverage. In 2009, 
the coverage for the first dose of measles-containing 
vaccine in children aged 12 months was estimated at 
85.1% (95% confidence interval (CI): 82.4–87.8), but 
reached the target of 95% (95% CI: 93.4–95.8) in chil-
dren aged 18 months [25]. Despite this fairly high vac-
cination coverage in the 18 month-olds, it is of note 
that families not registered with a family physician 
are not represented in this analysis. Lately a shrink-
ing confidence in vaccination has been observed in 
Romania, reflecting the progress of the anti-vaccine 
movement all over Europe. The ethnic group of the 
Roma is traditionally underserved by national health 
services and moreover, a part of them refuse vaccina-
tion actively. The current and previous Romanian out-
breaks started in Roma communities and underline 
the need to develop strategies to improve their inte-
gration into the national health services. However, we 
want to make clear that any under-vaccinated groups 
or those with a low immunity rate are highly prone to 
measles virus infections, and represent an important 
factor preventing successful and sustainable elimina-
tion of measles in Romania. Our results underline the 
importance to strengthen immunisation programmes 
and to develop specific measures to address parents 
and their concerns regarding vaccination as well as the 
hard-to-reach population all over Europe. 
In conclusion, a combination of epidemiological data 
and molecular characterisation enabled us to trace 
the spread of wild measles virus genotype in Romania 
from 2008 to 2012. Molecular surveillance of measles 
virus circulation in Romania will be continued to assess 
the effectiveness of the national measles control pro-
gramme and hopefully to support the verification of 
measles elimination by the year 2015.
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